Thadd M. Vargas is VP at DEPOMED INC (DEPO). They have made 11 open-market trades across 1 company since 2013, most recently 2017-06-13.
CIK 0001005201
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DEPO | 19,816 | $145K |
Shares reported on the most recent Form 4, priced at the 2017-06-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DEPO | SELL | 2017-06-13 | 2017-06-15 | $9.54 | $1.9M | +10.5% | +10.7% | -32.8% |
| DEPO | SELL | 2017-06-13 | 2017-06-15 | $9.54 | $3.7M | +10.5% | +10.7% | -32.8% |
| DEPO | SELL | 2017-05-11 | 2017-05-15 | $12.03 | $602K | -11.9% | -17.4% | -48.1% |
| DEPO | SELL | 2016-09-21 | 2016-09-22 | $25.00 | $281K | -0.2% | -7.9% | -29.2% |
| DEPO | SELL | 2016-08-10 | 2016-08-11 | $20.92 | $1.1M | -1.3% | +1.6% | -8.2% |
| DEPO | SELL | 2016-05-23 | 2016-05-25 | $20.00 | $300K | +1.2% | -6.5% | +5.2% |
| DEPO | SELL | 2016-05-10 | 2016-05-10 | $17.64 | $265K | +10.0% | +13.9% | +17.2% |
| DEPO | SELL | 2016-03-11 | 2016-03-11 | $16.00 | $368K | -17.9% | +2.7% | +28.9% |
| DEPO | SELL | 2016-03-02 | 2016-03-04 | $15.18 | $152K | -7.5% | -6.1% | +36.3% |
| DEPO | SELL | 2015-06-12 | 2015-06-15 | $20.70 | $104K | -20.6% | +2.4% | +2.4% |
| DEPO | SELL · 10b5-1 | 2014-12-02 | 2014-12-03 | $15.85 | $131K | -20.6% | +2.4% | +2.4% |
| DEPO | SELL | 2014-03-14 | 2014-03-14 | $14.69 | $938K | -20.6% | +2.4% | +2.4% |
| DEPO | SELL · 10b5-1 | 2013-12-02 | 2013-12-04 | $8.40 | $44K | -20.6% | +2.4% | +2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.